Disc Medicine, Inc. Income Taxes Paid
Disc Medicine, Inc. (IRON) reported Income Taxes Paid of $349.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-02-26
- Disc Medicine, Inc. income taxes paid, net for the quarter ending 2024-12-31 was $263.00K, a 1095.45% increase year-over-year.
- Disc Medicine, Inc. income taxes paid, net for the quarter ending 2024-09-30 was $4.00K, a 94.87% decline year-over-year.
- Disc Medicine, Inc. income taxes paid, net for the quarter ending 2024-06-30 was $33.00K.
- Disc Medicine, Inc. income taxes paid, net for the quarter ending 2024-03-31 was $0.00.
- Disc Medicine, Inc. income taxes paid, net for fiscal 2025 was $349.00K, a 16.33% increase from fiscal 2024.
- Disc Medicine, Inc. income taxes paid, net for fiscal 2024 was $300.00K, a 200.00% increase from fiscal 2023.
- Disc Medicine, Inc. income taxes paid, net for fiscal 2023 was $100.00K.
- Disc Medicine, Inc. income taxes paid, net for fiscal 2022 was $0.00.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month | Income Taxes Paid, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $349.00K 10-K · filed 2026-02-26 | ||||
| 2024-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $267.00K derived: sum of 2 quarters · filed 2026-02-26 | $300.00K derived: sum of 3 quarters · filed 2026-02-26 | $300.00K 10-K · filed 2026-02-26 | $299.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $37.00K derived: sum of 2 quarters · filed 2024-11-12 | $37.00K 10-Q · filed 2024-11-12 | $59.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $33.00K 10-Q · filed 2024-08-08 | $55.00K derived: sum of 3 quarters · filed 2026-02-26 | $133.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $22.00K derived: sum of 2 quarters · filed 2026-02-26 | $100.00K derived: sum of 3 quarters · filed 2026-02-26 | $100.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $100.00K derived: sum of 2 quarters · filed 2026-02-26 | $100.00K derived: sum of 3 quarters · filed 2026-02-26 | $100.00K 10-K · filed 2026-02-26 | $112.00K 10-K · filed 2024-03-21 |
| 2023-09-30 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $78.00K derived: sum of 2 quarters · filed 2024-11-12 | $78.00K 10-Q · filed 2024-11-12 | $78.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-15 | ||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |